GL1X · GenesisL1 explorer

UniProt Q16716

Pyruvate kinase (Q16716)

Pyruvate kinase (UniProt Q16716), EC 2.7.1.40: 23 experimental structures on GenesisL1, 19 ligands bound, 120 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q16716
Protein
Pyruvate kinase
EC
2.7.1.40
Experimental structures
23
Predicted models
0
Ligands
19
Pockets
120 · 6 records with a druggable one

Structures

23 records of Q16716 in the MolNFT archive: 23 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
5SC8Structure of liver pyruvate kinase in complex with anthraquinone derivative 17x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, E6K, MG, K—
5SC9Structure of liver pyruvate kinase in complex with anthraquinone derivative 29x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I7K, MG—
5SCAStructure of liver pyruvate kinase in complex with anthraquinone derivative 36x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I7N, MG, K—
5SCBStructure of liver pyruvate kinase in complex with anthraqui derivative 28x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I7V, MG, K20 (best 0.87)
5SCBStructure of liver pyruvate kinase in complex with anthraquinone derivative 28x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I7V, MG, K—
5SCCStructure of liver pyruvate kinase in complex with anthraqui derivative 57x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I8Q20 (best 0.87)
5SCCStructure of liver pyruvate kinase in complex with anthraquinone derivative 57x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I8Q—
5SCDStructure of liver pyruvate kinase in complex with anthraqui derivative 58x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I8U20 (best 0.87)
5SCDStructure of liver pyruvate kinase in complex with anthraquinone derivative 58x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I8U—
5SCEStructure of liver pyruvate kinase in complex with anthraquinone derivative 55x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I8Y—
5SCFStructure of liver pyruvate kinase in complex with anthraqui derivative 99x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I91—
5SCFStructure of liver pyruvate kinase in complex with anthraquinone derivative 99x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I91—
5SCGStructure of liver pyruvate kinase in complex with anthraqui derivative 101x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I99, MG, K20 (best 0.87)
5SCGStructure of liver pyruvate kinase in complex with anthraquinone derivative 101x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I99, MG, K—
5SCHStructure of liver pyruvate kinase in complex with anthraqui derivative 100x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9C—
5SCHStructure of liver pyruvate kinase in complex with anthraquinone derivative 100x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9C—
5SCIStructure of liver pyruvate kinase in complex with anthraqui derivative 105x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9F20 (best 0.87)
5SCIStructure of liver pyruvate kinase in complex with anthraquinone derivative 105x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9F—
5SCJStructure of liver pyruvate kinase in complex with anthraqui derivative 106x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9K20 (best 0.87)
5SCJStructure of liver pyruvate kinase in complex with anthraquinone derivative 106x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9K—
5SCKStructure of liver pyruvate kinase in complex with anthraquinone derivative 42x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, I9N—
5SCLStructure of liver pyruvate kinase in complex with anthraquinone derivative 1x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, AZN, MG, K—
5SDTStructure of liver pyruvate kinase in complex with anthraquinone derivative 15x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, I9Q, MG, K—

Ligands

  • FBP · 1,6-di-O-phosphono-beta-D-fructofuranose · in 23 records
  • MG · Magnesium ion · in 23 records
  • OXL · Oxalate ion · in 23 records
  • K · Potassium ion · in 22 records
  • I7V · (3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid · in 2 records
  • I8Q · 4-amino-3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid · in 2 records
  • I8U · 3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid · in 2 records
  • I91 · N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycine · in 2 records
  • I99 · (3R)-1-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carboxylic acid · in 2 records
  • I9C · methyl N-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)glycinate · in 2 records
  • I9F · dimethyl (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioate · in 2 records
  • I9K · (2R)-2-hydroxy-2-{2-[4-(3-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperazin-1-yl]-2-oxoethyl}butanedioic acid · in 2 records
  • AZN · Alizarin red · in 1 record
  • E6K · 5-[(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)amino]pentanoic acid · in 1 record
  • I7K · 1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-4-carboxylic acid · in 1 record
  • I7N · N-[(3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carbonyl]-L-aspartic acid · in 1 record
  • I8Y · 3-amino-4-hydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid · in 1 record
  • I9N · 1,2-dihydroxy-3-(piperazine-1-sulfonyl)anthracene-9,10-dione · in 1 record
  • I9Q · N-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)-beta-alanine · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.